Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Company Profile and bullboard matches:

V.TFM , BLOK , ANEW , DTOC , DTOCU , DAPP , KGHG
Sort by: Date|Relevance

Think zinc: Another metal that can transform the energy storage sector

By Ron MacDonald, President and CEO of Zinc8 Energy Solutions Inc. Mines worldwide extract more than 11.9 million metric tons of zinc annually. There are zinc mines in over 50 countries around the world, and while the metal plays a key role in the steel industry, few ...

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX

Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. Advanced medical genetics company Invitae Corp. (NVTA:NYSE) and genomics analysis firm ArcherDX today...

This Is What First Lagarde’s Speech Means for Gold

Overbought and oversold Learning to master the markets is like drinking from a fire hose. This does not change, no matter at what stage of the game you are. The vastness of possibilities and the challenges of psychology are endless. Therefore the only way of mane...

New Century Resources, Alcidion Group, Telix Pharmaceutical, Marley Spoon - emerging ASX companies

The Australian stock exchange, which is based in Sydney, has been called the Australian Securities Exchange (ASX) since 2006. Since 1987, the trading place for securities has been located at this central location. Previously, the business with investments in various cities was...

Q&A with Cerro de Pasco Resources: Newly appointed CTO on the value of sustainable mining

If the World Economic Forum is any authority on the subject, the mining and metals sector – in its inherent connection to almost all industry value chains – “is an integral part of any foreseeable economy and society.” To that end, and with an ever-growi...

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...

Protagonist Therapeutics Shares Trade Up 70% on Phase 2 Transfusion Trial Results

Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher today after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia. Clinical-stage biopharmaceutical company Protago...
1 2 3 4 5